| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | selumetinib:BRD-A02303741 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.089 | 0.01 |
| mRNA | GMX-1778 | CTRPv2 | pan-cancer | AAC | 0.09 | 0.01 |
| mRNA | XMD13-2 | GDSC1000 | pan-cancer | AAC | 0.081 | 0.01 |
| mRNA | masitinib | GDSC1000 | pan-cancer | AAC | 0.083 | 0.01 |
| mRNA | BRD-K29313308 | CTRPv2 | pan-cancer | AAC | 0.092 | 0.01 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | 0.13 | 0.01 |
| mRNA | CX-5461 | GDSC1000 | pan-cancer | AAC | 0.081 | 0.01 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | 0.081 | 0.01 |
| mRNA | vorapaxar | CTRPv2 | pan-cancer | AAC | 0.093 | 0.01 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.12 | 0.01 |